CoChat

Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study.

Nosten, F, van Vugt, M, Price, R, Luxemburger, C, Thway, KL, Brockman, A, McGready, R, ter Kuile, F, Looareesuwan, S, White, NJ · 2000 · The Lancet

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Background Worsening drug resistance in Plasmodium falciparum malaria is a major threat to health in tropical countries. We did a prospective study of malaria incidence and treatment in an area of highly multidrug-resistant P. falciparum malaria. Methods We assessed incidence of P. falciparum malaria and the in-vivo responses to mefloquine treatment over 13 years in two large camps for displaced Karen people on the northwest border of Thailand. During this time, the standard mefloquine dose was first increased, and then combined artesunate and mefloquine was introduced as first-line treatment for uncomplicated P. falciparum malaria. Findings Early detection and treatment controlled P. falciparum malaria initially while mefloquine was effective (cure rate with mefloquine [15 mg/kg] and sulphadoxine-pyrimethamine in 1985, 98% [95% CI 97-100]), but as mefloquine resistance developed, the cure rate fell (71% [67-77] in 1990). A similar pattern was seen for high-dose (25 mg/kg) mefloquine monotherapy from 1990-94. Since the general deployment of the artesunate-mefloquine combination in 1994, the cure rate increased again to almost 100% from 1998 onwards, and there has been a sustained decline in the incidence of P. falciparum malaria in the study area. In-vitro susceptibility of P. falciparum to mefloquine has improved significantly (p=0.003). Interpretation In this area of low malaria transmission, early diagnosis and treatment with combined artesunate and mefloquine has reduced…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(00)02505-8

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 24 references

Cited by

See all 556

Metadata

Authors
Nosten, F., van Vugt, M., Price, R., Luxemburger, C., Thway, K., Brockman, A., McGready, R., ter Kuile, F., Looareesuwan, S., & White, N.
Affiliations
Mahidol University (TH)
Venue
The Lancet
Publisher
Elsevier BV
Published
2000-07
Volume
356
Issue
9226
Pages
297-302
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2130853973
Cited by
500
References
24
Citations by year
2026: 3 · 2025: 3 · 2024: 8 · 2023: 1 · 2022: 6 · 2021: 11 · 2020: 12 · 2019: 11 · 2018: 13 · 2017: 10 · 2016: 15 · 2015: 10 · 2014: 19 · 2013: 20 · 2012: 22
FWCI
27.35
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
Funders
  • Northwestern University
  • Wellcome Trust (091625)
  • University of Oxford
  • Mahidol University
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Phytochemical compounds biological activities
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
Keywords
falciparum malaria, mefloquine resistance, antimalarial drug resistance, malaria incidence, cure rate, sulfadoxine-pyrimethamine, in vitro susceptibility, artemisinin-based combination therapy, early diagnosis and treatment, western Thailand
MeSH terms
Artesunate, Animals, Antimalarials, Drug Therapy, Combination, Female, Humans, Male, Plasmodium falciparum, Pregnancy, Prospective Studies, Random Allocation, Sesquiterpenes, Thailand, Cohort Studies, Pregnancy Complications, Parasitic, Mefloquine, Incidence, Malaria, Falciparum, Drug Resistance, Multiple, Artemisinins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. https://app.cochat.ai/papers/10.1016/s0140-6736(00)02505-8
The paper
Nosten, F., van Vugt, M., Price, R., Luxemburger, C., Thway, K., Brockman, A., McGready, R., ter Kuile, F., Looareesuwan, S., & White, N. (2000). Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. The Lancet. https://doi.org/10.1016/s0140-6736(00)02505-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.